title: Treating diabetes mellitus in Prader-Willi syndrome with Exenatide.
abstract: We report the use of Exenatide, a GLP-1 agonist, in the management of diabetes mellitus in a 19 year-old female with Prader-Willi syndrome. The beneficial effects of Exenatide in weight reduction and appetite suppression provide a promising strategy for the treatment of obesity and diabetes mellitus in Prader-Willi syndrome.
authors.affiliation: Department of Medicine, Nottingham University Hospitals NHS Trust, NG5 1PB, United Kingdom. ian.seetho@nhs.net
authors.forename: Ian W
authors.initials: IW
authors.lastname: Seetho
authors.forename: Gavin
authors.initials: G
authors.lastname: Jones
authors.forename: George A
authors.initials: GA
authors.lastname: Thomson
authors.forename: Devaka J S
authors.initials: DJ
authors.lastname: Fernando
mesh_terms: D000328:Adult; D003920:Diabetes Mellitus / Q000188:drug therapy*; D000077270:Exenatide; D005260:Female; D054439:Ghrelin / Q000627:therapeutic use; D006801:Humans; D010455:Peptides / Q000627:therapeutic use*; D011218:Prader-Willi Syndrome / Q000188:drug therapy*; D014688:Venoms / Q000627:therapeutic use*; D055815:Young Adult
chemical_list: D054439:Ghrelin; D010455:Peptides; D014688:Venoms; D000077270:Exenatide